207_Combined course Presentations
SCLC/LCNEC: State of the art treatment
Platinum (either cis or carbo) combination chemotherapy (i.e cis/carbo- etoposide) x 4-6 courses q 3 weeks “standard of care” 1 st line therapy for both LD and ED
Combined chemotherapy and thoracic radiotherapy (preferably early concurrent) standard of care for LD
Possible role of upfront surgery in very limited disease
Second line therapy: Topotecan o CAV or PE-rechallenge based on treatment-free interval (refractory vs sensitive disease)
PCI for pts with both LD or ED with good response to 1 st line therapy
Thoracic irradiation in ED ?
Made with FlippingBook